Need professional-grade analysis? Visit stockanalysis.com
$32.42B
N/A
N/A
131.00%
Price Chart
Risk-Adjusted Performance
Otsuka Holdings Co. Ltd (OTSKF) Price Performance
Otsuka Holdings Co. Ltd (OTSKF) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at $69.59.
Over the past year, OTSKF has traded between a low of $44.08 and a high of $70.34. The stock has gained 49.2% over this period. It is currently 57.9% above its 52-week low.
Otsuka Holdings Co. Ltd has a market capitalization of $32.42B and a dividend yield of 131.00%.
About Otsuka Holdings Co. Ltd
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.
Company Info
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $2.47T
- EBITDA
- $589.93B
- Profit Margin
- 14.71%
- EPS (TTM)
- 4.29
- Book Value
- 36.07
Technical Indicators
- 52 Week High
- $70.34
- 52 Week Low
- $44.08
- 50 Day MA
- $60.97
- 200 Day MA
- N/A
- Beta
- -0.08
Valuation
- Trailing P/E
- 14.32
- Forward P/E
- N/A
- Price/Sales
- 0.01
- Price/Book
- 1.70
- Enterprise Value
- $-203,600,330,752